EUVIMEDEUVIMED entdecken
Crossref

Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages

Qin Hu, Li Zhang, YiTing Tao, ShuangLin Xie, AiYun Wang, Caiying Luo, RenHua Yang, Zhiqiang Shen, Bo He, Yu Fang, Peng Chen

Pharmacology · 2024

DOI: 10.1159/000540654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, 2024. Verfasst von Qin Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming, China. Hauptthemen laut MEDLINE: Macrophages, Hepatocytes, Non-alcoholic Fatty Liver Disease, Glucagon-Like Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Non-alcoholic fatty liver disease (NAFLD) is currently the most common type of chronic liver disease. Semaglutide is a glucose-lowering drug administered for the treatment of type 2 diabetes mellitus (T2DM) and is clinically effective in the treatment of NAFLD. X-box binding protein 1 (XBP1) is related to the pathogenesis of both NAFLD and T2DM. The aim of the present study was to demonstrate whether the underlying mechanism of semaglutide treatment for NAFLD is via downregulation of the inositol-requiring transmembrane kinase/endonuclease-1α (IRE1α)-XBP1-CCAAT/enhancer binding protein α (C/EBPα) signaling pathway in macrophages.

Methods

In the present study, NAFLD cell modeling was induced by oleic acid (0.4 mm) and palmitic acid (0.2 mm). Hepatocytes (AML12) and macrophages (RAW264.7) were co-cultured in 6-well Transwell plates. Semaglutide (60 or 140 nm) was administrated for 24 h, while pioglitazone (2 μm) and toyocamycin (200 nm) were used as a positive control drug and a XBP1 inhibitor, respectively. Autophagy and apoptosis of AML12 cells were detected by transmission electron microscopy and Western blotting (WB). Hepatocyte steatosis was evaluated by adopting total intracellular triglyceride determination, analysis of the relative expression of proteins and genes associated with lipid metabolism and hepatocyte Oil red O staining. Detection of inflammation factors was conducted by ELISA and WB. To explore the underlying mechanism of NAFLD treatment with semaglutide, the relative expression of related proteins and genes were tested.

Results

Our study demonstrated that semaglutide treatment improved autophagy and inhibited apoptosis of hepatocytes, while notably ameliorating steatosis of hepatocytes. In addition, inflammation was attenuated in the NAFLD cell co-culture model after semaglutide administration. Semaglutide also significantly reduced the protein and gene expression levels of the IRE1α-XBP1-C/EBPα signaling pathway in macrophages.

Conclusion

Semaglutide partially ameliorated NAFLD by downregulating the IRE1α-XBP1-C/EBPα signaling pathway in macrophages. These findings may provide a potential theoretical basis for semaglutide therapy for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesHepatocytesNon-alcoholic Fatty Liver DiseaseGlucagon-Like PeptidesAnimalsMiceX-Box Binding Protein 1Signal TransductionDown-RegulationProtein Serine-Threonine KinasesCoculture TechniquesRAW 264.7 CellsEndoribonucleasesCCAAT-Enhancer-Binding Protein-alphaApoptosisCCAAT-Enhancer-Binding ProteinsGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

Co-cultureMacrophageNon-alcoholic fatty liver diseaseSemaglutideXBP1

Substanzen

X-Box Binding Protein 1Protein Serine-Threonine KinasesGlucagon-Like PeptidesEndoribonucleasesCCAAT-Enhancer-Binding Protein-alphaCCAAT-Enhancer-Binding ProteinsGlucagon-Like Peptide 1SemaglutideErn1 protein, mouseXbp1 protein, mouse

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming, China.
  • Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • College of Modern Biomedical Industry, Kunming Medical University, Kunming, China.

Zitieren

APA

Hu, Q., Zhang, L., Tao, Y., Xie, S., Wang, A., Luo, C., Yang, R., Shen, Z., He, B., Fang, Y., & Chen, P. (2024). Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages. Pharmacology. https://doi.org/10.1159/000540654

Vancouver

Hu Q, Zhang L, Tao Y, Xie S, Wang A, Luo C, et al. Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages. Pharmacology. 2024. doi:10.1159/000540654

BibTeX
@article{Hu2024,
  author = {Hu, Qin and Zhang, Li and Tao, YiTing and Xie, ShuangLin and Wang, AiYun and Luo, Caiying and Yang, RenHua and Shen, Zhiqiang and He, Bo and Fang, Yu and Chen, Peng},
  title = {Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages},
  journal = {Pharmacology},
  year = {2024},
  doi = {10.1159/000540654}
}
Kostenlos starten →